Procalcitonin Monitoring Sepsis Study
NCT01523717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 858
Last updated 2015-03-17
Summary
The purpose of this study is to investigate the relationship between a procalcitonin decrease over 72 hours and outcome in patients who have severe sepsis or septic shock.
Conditions
- Severe Sepsis
- Septic Shock
Sponsors & Collaborators
-
Brahms AG
lead INDUSTRY
Principal Investigators
-
Nathan Shapiro, MD · Beth Israel Deaconess Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-03-31
Countries
- United States
Study Locations
More Related Trials
-
Mortality Due to Septic Shock Associated With Thrombocytopenia
NCT03617965 ·Status: UNKNOWN
-
A Prediction Model of 28-day Mortality in Septic Shock
NCT04915625 ·Status: UNKNOWN
-
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 ·Status: UNKNOWN
-
Comparative Study of the Protein C Pathway in Septic and Non Septic Patients With Organ Failure
NCT00361725 ·Status: TERMINATED
-
Procalcitonin in Diagnosis of Bacterial Infections in Young Infants
NCT03509727 ·Status: COMPLETED
-
Procalcitonin in Diagnosis of Sepsis in Critically Ill Patient
NCT04105400 ·Status: UNKNOWN
-
Comparison Between the Progostic Value of the Procalcitonin and the Platelet/Total Leukocytic Count Ratio in Sepsis
NCT06991686 ·Status: COMPLETED
-
Sensitivity and Specificity of Leucocytes Profiling Versus Platelet Indices in Prediction of Clinical Outcome for Candidates With Sepsis. A Bi-centric Observational Clinical Trial
NCT06612307 ·Status: COMPLETED
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Sepsis Early EvaluatioN Through Rapid Ultrasound and veNous Gas Analysis
NCT05787184 ·Status: UNKNOWN
-
Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome
NCT05383963 ·Status: RECRUITING
-
Early Detection of At-risk Septic Patients
NCT06253325 ·Status: RECRUITING
-
A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis
NCT03333304 ·Status: COMPLETED ·Phase: NA
-
Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections
NCT00934011 ·Status: COMPLETED ·Phase: NA
-
Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis
NCT02576457 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of the Prognostic Value of Immature Platelet Fraction
NCT07039227 ·Status: COMPLETED
-
Platelet Reactivity in Septic Shock
NCT03716310 ·Status: COMPLETED
-
Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.
NCT07200817 ·Status: RECRUITING
-
Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.
NCT01411670 ·Status: COMPLETED ·Phase: PHASE2
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C
NCT02885168 ·Status: COMPLETED ·Phase: PHASE4
-
Cytokine Response in Septic Shock
NCT01770457 ·Status: UNKNOWN
-
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
NCT02871895 ·Status: UNKNOWN
-
Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection
NCT00407147 ·Status: TERMINATED ·Phase: PHASE4
-
Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta Sofa
NCT01841190 ·Status: UNKNOWN